Post-transplant cyclophosphamide for graft-versus-host disease prophylaxis in HLA matched sibling or matched unrelated donor transplant for patients with acute leukemia, on behalf of ALWP-EBMT.

MLA

Ruggeri, Annalisa, et al. “Post-Transplant Cyclophosphamide for Graft-versus-Host Disease Prophylaxis in HLA Matched Sibling or Matched Unrelated Donor Transplant for Patients with Acute Leukemia, on Behalf of ALWP-EBMT.” Journal of Hematology & Oncology, vol. 11, no. 1, Mar. 2018, p. 40. EBSCOhost, https://doi.org/10.1186/s13045-018-0586-4.

APA

Ruggeri, A., Labopin, M., Bacigalupo, A., Afanasyev, B., Cornelissen, J. J., Elmaagacli, A., Itälä-Remes, M., Blaise, D., Meijer, E., Koc, Y., Milpied, N., Schouten, H. C., Kroeger, N., Mohty, M., & Nagler, A. (2018). Post-transplant cyclophosphamide for graft-versus-host disease prophylaxis in HLA matched sibling or matched unrelated donor transplant for patients with acute leukemia, on behalf of ALWP-EBMT. Journal of Hematology & Oncology, 11(1), 40. https://doi.org/10.1186/s13045-018-0586-4

Chicago

Ruggeri, Annalisa, Myriam Labopin, Andrea Bacigalupo, Boris Afanasyev, Jan J Cornelissen, Ahmet Elmaagacli, Maija Itälä-Remes, et al. 2018. “Post-Transplant Cyclophosphamide for Graft-versus-Host Disease Prophylaxis in HLA Matched Sibling or Matched Unrelated Donor Transplant for Patients with Acute Leukemia, on Behalf of ALWP-EBMT.” Journal of Hematology & Oncology 11 (1): 40. doi:10.1186/s13045-018-0586-4.